Jennifer Hockings

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2B6</i> and Efavirenz‐Containing Antiretroviral Therapy

Zeruesenay Desta, Roseann S. Gammal, Li Gong et al. · Clinical Pharmacology & Therapeutics · 2019 · 179 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

An Estrogen Receptor-α/p300 Complex Activates the BRCA-1 Promoter at an AP-1 Site That Binds Jun/Fos Transcription Factors: Repressive Effects of p53 on BRCA-1 Transcription

Brandon D. Jeffy, Jennifer Hockings, Michael Q. Kemp et al. · Neoplasia · 2005 · 91 citations · Full text

Medicine, Genetics, Oncology +14

The Ligand Status of the Aromatic Hydrocarbon Receptor Modulates Transcriptional Activation of BRCA-1 Promoter by Estrogen

Jennifer Hockings, Patricia A. Thorne, Michael Q. Kemp et al. · Cancer Research · 2006 · 90 citations

Medicine, Oncology, Toxicology +17

Identification and characterization of a new G-quadruplex forming region within the kRAS promoter as a transcriptional regulator

Rhianna K. Morgan, Harshul Batra, Vanessa C. Gaerig et al. · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2015 · 71 citations

Life Sciences, Genetics, Molecular Biology +16

Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes

Chuang Liu, Junfei Zhao, Weiqiang Lü et al. · PLoS Computational Biology · 2020 · 52 citations · Full text

Medicine, Genetics, Oncology +17